Drug development – Page 19

Poor validation of capsule disintegration testing for gelatin-free capsules.

Poor validation of capsule disintegration testing for gelatin-free capsules. Poor validation of capsule disintegration testing for gelatin-free capsules. Introduction: In the pharmaceutical industry, ensuring the efficacy and safety of oral…

Managing Hardness Failures in Bilayer Tablets During Testing

Managing Hardness Failures in Bilayer Tablets During Testing Managing Hardness Failures in Bilayer Tablets During Testing Introduction: In the pharmaceutical industry, bilayer tablets have emerged as a sophisticated solution for…

Addressing Challenges in Friability Testing for Sugar-Coated Tablets

Addressing Challenges in Friability Testing for Sugar-Coated Tablets Addressing Challenges in Friability Testing for Sugar-Coated Tablets Introduction: In the pharmaceutical industry, ensuring the quality and durability of solid dosage forms…

Ensuring Compliance with Regulatory Guidelines for Extended Release Tablets

Ensuring Compliance with Regulatory Guidelines for Extended Release Tablets Ensuring Compliance with Regulatory Guidelines for Extended Release Tablets Introduction: Extended release tablets are a crucial innovation in pharmaceutical dosage forms,…

Managing Failures in Stress Tests for Sustained Release Tablets

Managing Failures in Stress Tests for Sustained Release Tablets Managing Failures in Stress Tests for Sustained Release Tablets Introduction: Sustained release tablets are critical in modern pharmaceutical formulations, offering controlled…

Problems with ensuring consistent drug release profiles during stability studies.

Problems with ensuring consistent drug release profiles during stability studies. Problems with ensuring consistent drug release profiles during stability studies. Introduction: In the pharmaceutical industry, stability studies are essential for…

Resolving Failures in Disintegration Testing for High-Dose Tablets

Resolving Failures in Disintegration Testing for High-Dose Tablets Resolving Failures in Disintegration Testing for High-Dose Tablets Introduction: In the pharmaceutical industry, the production of high-dose tablets is a critical process…

Addressing Heat Sensitivity of APIs During Validation of Coated Tablets

Addressing Heat Sensitivity of APIs During Validation of Coated Tablets Addressing Heat Sensitivity of APIs During Validation of Coated Tablets Introduction: The pharmaceutical industry continuously strives to enhance the efficacy,…

Addressing Challenges in Coating Integrity Tests During Stability Studies

Addressing Challenges in Coating Integrity Tests During Stability Studies Addressing Challenges in Coating Integrity Tests During Stability Studies Introduction: In the pharmaceutical industry, the stability of a drug product is…

Controlling Binder Distribution in Wet Granulation Processes

Controlling Binder Distribution in Wet Granulation Processes Controlling Binder Distribution in Wet Granulation Processes Introduction: In the pharmaceutical industry, the wet granulation process is a critical method for producing tablets.…

Poor reproducibility in monitoring capsule disintegration profiles.

Poor reproducibility in monitoring capsule disintegration profiles. Poor reproducibility in monitoring capsule disintegration profiles. Introduction: The disintegration profile of capsules is a critical quality attribute that significantly impacts the bioavailability…

Ensuring Robustness in Disintegration Tests for High-Dose Tablets

Ensuring Robustness in Disintegration Tests for High-Dose Tablets Ensuring Robustness in Disintegration Tests for High-Dose Tablets Introduction: In the pharmaceutical industry, high-dose tablets serve as a critical vehicle for delivering…